Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Gerald J, Elfenbein"'
Autor:
Peter J. Quesenberry, Eric S. Winer, Ritesh Rathore, David Berz, L. Colvin, Lawrence G. Lum, Gerald A. Colvin, Patricia Karwan, Elise M. McCormack, Gerald J. Elfenbein
Publikováno v:
Transplantation Proceedings. 41:3863-3867
Background Tandem high-dose melphalan therapy with autologous peripheral stem cell support has emerged as the standard of care for patients without prohibitive comorbidities. Mucositis and gastrointestinal side effects are the most common extrahemato
Autor:
David Berz, Gerald J. Elfenbein, Eric S. Winer, Loren D. Fast, Peter J. Quesenberry, Gerald A. Colvin, Muthalagu Ramanathan
Publikováno v:
Biology of Blood and Marrow Transplantation. 15:421-431
Allogeneic bone marrow transplantation relies on immunosuppression, which controls graft-versus-host disease (GVHD) and allows engraftment at the expense of diminished graft versus-tumor (GVT) activity. Advances in hematologic transplantation have pr
Autor:
Asad Bashey, Waleska S. Pérez, Peter H. Wiernik, Robert Peter Gale, Donna E. Reece, Martha Q. Lacy, Karen K. Ballen, David H. Vesole, Gerald J. Elfenbein, Mei-Jie Zhang, Shaji Kumar, Gustavo Milone, Robert A. Kyle, L. Bik To, Mitchell S. Cairo, Jan S. Moreb, Christopher Bredeson, Parameswaran Hari, Hillard M. Lazarus, Cesar O. Freytes, Philip L. McCarthy, John Gibson, Santiago Pavlovsky
Publikováno v:
Biology of Blood and Marrow Transplantation. 14:1134-1140
Nonsecretory myeloma (NSM) accounts for
Autor:
Jakob Passweg, Mary M. Horowitz, Jorg Dieter Seebach, Jon J. van Rood, Pierre Tiberghien, A. John Barrett, Gerald J. Elfenbein, Eliane Gluckman, James Gajewski, Martin Goerner, Georg Stussi, Olle Ringdén, Brian J. Bolwell, Philip A. Rowlings, Fausto R. Loberiza, Thomas R. Klumpp, Vijay Reddy, Armand Keating, Robert Peter Gale
Publikováno v:
Biology of Blood and Marrow Transplantation. 11(12):1006-1013
Reports have shown a worse outcome for donor-recipient pairs mismatched for ABO blood groups in bone marrow transplantation (BMT). These studies, however, included small and heterogenous study populations, and not all considered bidirectional ABO inc
Publikováno v:
Clinical Prostate Cancer. 3:112-121
The bispecific antibody (BiAb) anti-CD3 x anti-Her2/neu (Her2Bi), combines Her2/neu targeting with nonmajor histocompatibility complex-restricted cytotoxicity mediated by activated T cells (ATCs). To evaluate this adaptive immunotherapeutic strategy
Publikováno v:
Blood Cells, Molecules, and Diseases. 32:106-111
For more than a decade, the notion that peripheral blood-derived stem cells engraft more rapidly than bone marrow-derived stem cells after high-dose therapy has dominated our thinking. Recently, reports that granulocyte colony-stimulating factor (G-C
Autor:
Waleska S. Pérez, Christopher Bredeson, Santiago Pavlovsky, Stephen D. Nimer, Donna E. Reece, P.L. McCarthy, Gerald J. Elfenbein, David H. Vesole, Cesar O. Freytes, Deborah Marcellus, Mei-Jie Zhang, Amy K. Keating, Daniel J. Weisdorf, Robert Peter Gale, John R. Wingard, Sergio Giralt, Sundar Jagannath, L. B. To, Morie A. Gertz, Dipnarine Maharaj, John Gibson, Peter H. Wiernik, Karen K. Ballen, Robert A. Kyle, Gustavo Milone
Publikováno v:
Bone Marrow Transplantation. 32:1135-1143
The role of autologous stem cell transplantation (AuSCT) in older multiple myeloma patients is unclear. Using data from the Autologous Blood and Marrow Transplant Registry, we compared the outcome of 110 patients/=the age of 60 (median 63; range 60-7
Autor:
Peter J. Quesenberry, Abby Maizel, K. Radie-Keane, Ritesh Rathore, Frank Cummings, Gerald J. Elfenbein, Gerald A. Colvin, Lawrence G. Lum
Publikováno v:
Clinical Breast Cancer. 4:212-217
Autor:
Robert Peter Gale, Brian J. Bolwell, Karen H. Antman, Andrew L. Pecora, Mary M. Horowitz, Juan Wu, Karen K. Fields, Hillard M. Lazarus, J D Rizzo, Stephanie F. Williams, Gerald J. Elfenbein
Publikováno v:
Bone Marrow Transplantation. 32:151-155
Metastatic breast cancer has been a common indication for autologous hematopoietic stem cell transplantation (HSCT). Previous reports indicate 3-year survival and progression-free survival (PFS) rates after autotransplant to be about 30 and 15%, resp
Publikováno v:
Blood. 101:771-778
The extravasation of leukocytes at sites of inflammation critically depends on initial shear-resistant adhesive interactions between leukocytes in blood flow and target tissue endothelium. Dermal lymphocytic infiltrates are a hallmark feature of acut